Sai Parenterals’ Australian subsidiary, Noumed Pharmaceuticals, has renewed an exclusive over-the-counter (OTC) medicines supply agreement with one of Australia’s leading pharmacy chains. The 7.5-year contract covers the supply of an expanded portfolio of OTC pharmaceutical products.

• Operational Scope: Noumed Pharmaceuticals will continue to manage the sourcing, manufacturing, and regulatory compliance of the OTC medicines supplied under the agreement.
• Agreement Timeline: The renewed agreement took effect on 1 July 2026 and will run for 7.5 years, with an option to extend for a further three years by mutual agreement.
• Supply Scope: The agreement supports the supply of an expanded OTC medicines portfolio to one of Australia’s leading pharmacy chains and is structured to add new products over the contract term.

This summary is based on a news article published by BioSpectrum Asia.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.